Dr. Amir Sanati Nezhad is an internationally respected biomedical engineer, healthcare innovator, entrepreneur, and commercialization strategist whose career has been defined by translating cutting-edge scientific discoveries into technologies that improve patient care. With more than two decades of professional experience spanning research, academia, entrepreneurship, product development, and strategic advisory work, Amir has become a recognized leader in the fields of medical devices, diagnostics, BioMEMS, microfluidics, digital health, and artificial intelligence-enabled healthcare. His ability to bridge scientific innovation with commercialization has positioned him as a trusted advisor to startups, growth-stage companies, academic institutions, healthcare organizations, and multinational industry partners seeking to accelerate innovation while reducing development risk.
Currently serving as Professor in the Department of Biomedical Engineering and the Department of Mechanical and Manufacturing Engineering at the University of Calgary, Amir also holds the prestigious appointment of Canada Research Chair in BioMEMS. As Principal Investigator of the BioMEMS and Bioinspired Microfluidic Laboratory, he leads multidisciplinary teams focused on developing transformative technologies in biosensors, organ-on-chip systems, tissue engineering, wearable technologies, molecular diagnostics, precision medicine, and point-of-care healthcare solutions. His research philosophy centers on solving meaningful clinical challenges through engineering excellence, interdisciplinary collaboration, and practical implementation, ensuring that laboratory discoveries ultimately reach patients and healthcare providers.
Amir’s educational journey reflects his lifelong commitment to engineering innovation and scientific excellence. After earning his Bachelor of Science in Mechanical Engineering from Isfahan University of Technology, he completed his Master of Science at Amirkabir University of Technology before receiving his Doctor of Philosophy in Mechanical Engineering from Concordia University. Following his doctoral studies, he completed prestigious postdoctoral fellowships at McGill University and the Harvard-MIT Division of Health Sciences and Technology, where he further expanded his expertise in microfluidics, disease modeling, diagnostics, and biomedical systems. These experiences laid the foundation for a career dedicated to advancing healthcare technologies with global relevance.
Throughout his academic career, Amir has established one of Canada’s leading research programs focused on translational biomedical engineering. His laboratory develops integrated healthcare platforms that combine microfluidics, BioMEMS, artificial intelligence, advanced biomaterials, and biosensing technologies to create innovative diagnostic and therapeutic solutions. His work spans infectious disease diagnostics, cancer detection, neurological assessment, drug discovery, precision medicine, digital health technologies, and advanced wearable systems. Many of these technologies have progressed beyond the research phase into commercialization, demonstrating his unique ability to bridge scientific discovery with real-world healthcare applications.
Beyond academia, Amir has built an impressive entrepreneurial portfolio that reflects his passion for healthcare innovation. As founder or co-founder of CriticareDx, Fluidome, Wireless Fluidics, and OfBrains, he has helped launch ventures dedicated to decentralized diagnostics, intelligent biosensing, artificial intelligence, autonomous sensing systems, precision medicine, and connected healthcare technologies. His entrepreneurial experience has provided him with firsthand expertise in venture creation, intellectual property development, regulatory planning, commercialization strategy, market entry, fundraising, technology transfer, and product development. This combination of academic leadership and startup experience allows him to advise organizations from both scientific and commercial perspectives.
Amir’s scholarly accomplishments are equally remarkable. He has authored more than 350 peer-reviewed publications, conference papers, and book chapters while serving as corresponding author on more than 170 scientific publications published in many of the world’s most respected journals, including Nature Communications, Proceedings of the National Academy of Sciences (PNAS), Journal of the American Chemical Society (JACS), Advanced Functional Materials, Advanced Science, Lab on a Chip, and ACS Sensors. Complementing this extraordinary publication record are seven patents and numerous commercially translatable technologies that demonstrate his commitment to creating innovations capable of improving healthcare delivery worldwide. His work has influenced the fields of diagnostics, microfluidics, tissue engineering, BioMEMS, biosensors, organ-on-chip systems, and digital medicine while helping establish new standards for translational biomedical research.
Equally impressive is Amir’s leadership in securing funding and building collaborative ecosystems. He has attracted more than $60 million in competitive research, innovation, and industry-supported funding while assisting organizations in securing millions more through strategic non-dilutive funding opportunities. His collaborations extend across hospitals, diagnostic companies, multinational corporations, government agencies, innovation organizations, and research institutes throughout Canada, Europe, China, the Middle East, and Asia-Pacific. Whether leading multidisciplinary research initiatives, evaluating emerging technologies, or advising healthcare startups, Amir consistently demonstrates an exceptional ability to unite scientific, clinical, engineering, and commercial stakeholders around shared objectives.
Throughout his career, Amir has received numerous prestigious honors recognizing both his research excellence and leadership. Among these distinctions are the Governor General’s Gold Medal of Canada, appointment as Canada Research Chair, the Douglas R. Colton Medal for Research Excellence, Peak Scholar recognition, the Killam Emerging Research Leader Award, Excellence in Teaching honors, and multiple distinguished research awards from the University of Calgary. Beyond these accolades, he has mentored more than 140 graduate students, researchers, engineers, and innovators who now serve in leadership positions across academia, healthcare, and industry. His dedication to developing future leaders reflects his belief that innovation succeeds when knowledge is shared generously and collaboratively.
Outside of his professional accomplishments, Amir values creativity, wellness, and lifelong learning. His passion for poetry reflects an appreciation for thoughtful expression and creative problem solving, while swimming provides balance and discipline that complement the demands of leadership. Fluent in both English and French, he enjoys collaborating across cultures and disciplines, recognizing that diverse perspectives often generate the strongest innovations. These personal qualities reinforce the collaborative leadership style that has earned him the respect of colleagues, entrepreneurs, clinicians, investors, and researchers around the world.
Today, Amir is actively pursuing board and advisory opportunities within the healthcare and medical device sectors, particularly with medium-sized companies and innovative startups where he can make the greatest strategic impact. He is motivated by the opportunity to help organizations identify technological and operational gaps, accelerate product development, strengthen commercialization strategies, and guide innovation from concept through market adoption. With expertise spanning market strategy, technology translation, scientific due diligence, commercialization planning, risk management, strategic partnerships, and healthcare innovation, Amir offers boards a rare combination of technical excellence, entrepreneurial insight, and global strategic perspective. His career stands as a testament to the belief that transformative healthcare innovation is achieved when scientific discovery is paired with visionary leadership, collaborative partnerships, and an unwavering commitment to improving lives.
Character:
Amir is guided by integrity, intellectual curiosity, and a genuine desire to improve global healthcare through meaningful innovation. He leads with humility and collaboration, consistently empowering multidisciplinary teams to pursue ambitious goals while maintaining the highest professional standards.
Knowledge:
With more than twenty years of experience in biomedical engineering, diagnostics, medical devices, digital health, and commercialization, Amir possesses an exceptional depth of scientific and strategic expertise. His extensive publication record, patents, entrepreneurial ventures, and international collaborations demonstrate a rare ability to translate knowledge into measurable impact.
Strategic:
Amir excels at identifying emerging opportunities, evaluating technology readiness, and developing commercialization strategies that reduce risk while accelerating growth. His experience spanning academia, startups, healthcare systems, and industry enables him to help organizations make informed decisions that create sustainable competitive advantages.
Communication:
An accomplished educator, mentor, and international speaker who effectively communicates complex scientific concepts to technical and non-technical audiences alike. His ability to build consensus among researchers, executives, investors, clinicians, and board members makes him a highly effective advisor and strategic leader.
